A Pilot Voucher Incentive for Improving Retention in Postpartum HIV Care in South Africa
A Pilot Study of a Voucher Incentive System for Improving Retention in Postpartum HIV Care in South Africa
1 other identifier
interventional
100
1 country
1
Brief Summary
Given there is substantial loss to follow-up soon after delivery among HIV-positive pregnant women in South Africa, we will conduct a pilot study of an innovative approach to improve retention in care targeted to this specific population at high risk of drop-out. The problem of poor retention in care is well documented, but interventions to address the issue are lacking. In order to design an effective intervention that will be tested in a future randomized controlled trial, we will first complete preliminary research via a pilot study in order to determine the feasibility and acceptability of an incentive program (i.e., a supermarket voucher) to reduce loss to follow-up among HIV-positive women after delivery. The primary objective of this study is to determine the feasibility of a voucher incentive intervention aimed at improving retention in postpartum HIV care Secondary objectives include: a) to determine the efficacy of the intervention at increasing postpartum retention; b) to determine the acceptability of the intervention in terms of women's preferences for the intervention compared to other possible interventions; c) to assess differences in patient retention among women newly diagnosed with HIV vs. those who knew their HIV-positive status before pregnancy; and d) to assess differences in patient retention among women who initiated ART during pregnancy vs. those who were on ART before becoming pregnant. We will enroll up to 200 adult (≥18 years), pregnant, HIV-positive women attending antenatal care who have not previously enrolled in the study at Hikhensile Clinic, Johannesburg, South Africa. The study will be a prospective intervention cohort study with historical controls. Intervention subjects will receive a one-time supermarket voucher of R50 (about $5.00) for participants who return for at least one postpartum visit at the study clinic within 10 weeks of delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv
Started Feb 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2015
CompletedFirst Posted
Study publicly available on registry
January 30, 2015
CompletedStudy Start
First participant enrolled
February 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedJanuary 5, 2018
January 1, 2018
2.4 years
January 22, 2015
January 3, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants who receive a voucher.
Defined as each participant who qualifies for a voucher successfully receiving the voucher via electronic transfer.
10 weeks
Study Arms (2)
Incentive Group
EXPERIMENTALA one-time supermarket voucher of R50 (about $5.00) for participants who return for at least one postpartum visit at the study clinic within 10 weeks of delivery
Control Group
NO INTERVENTIONStandard of care
Interventions
A one-time supermarket voucher of R50 (about $5.00) for participants who return for at least one postpartum visit at the study clinic within 10 weeks of delivery
Eligibility Criteria
You may qualify if:
- Adult (≥18 years of age)
- HIV-positive at the time of enrollment
- Pregnant
- Initiating ART on day of enrollment, or already initiated on ART
- Willing and able to provide written informed consent for study participation and data collection
- Able to speak and understand spoken English
- Must possess a working cell phone during the enrollment visit
- Not previously enrolled in the study
You may not qualify if:
- \- Patient requests to be transfered to non-study site for HIV care and treatment on day of recruitment/enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Universitylead
- Vanderbilt Universitycollaborator
- University of Witwatersrand, South Africacollaborator
Study Sites (1)
HIV Clinic
Johannesburg, Gauteng, 02476, South Africa
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew Fox, DSc
Boston University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 22, 2015
First Posted
January 30, 2015
Study Start
February 1, 2015
Primary Completion
July 1, 2017
Study Completion
July 1, 2017
Last Updated
January 5, 2018
Record last verified: 2018-01